https://www.selleckchem.com/pr....oducts/Rosuvastatin-
98, 95% confidence interval [CI] 0.76-1.26, 33 trials, 15,942 participants, moderate certainty of evidence). However, there was a moderate certainty of evidence that CQ/HCQ increases the incidence of cardiac complications (RR 1.62, 95% CI 1.10-2.38, 16 trials, 9908 participants). No clear relationship was observed between CQ/HCQ and retinopathy (OR 1.63, 95% CI - 0.4-6.57, 5 trials, 344 participants, very low certainty of evidence). CQ and HCQ probably do not increase SAEs, with low frequency of these adverse event
Like
Comment
Share
